MR Diffusion Perfusion Mismatch
Overview
Olea Medical’s MR Diffusion Perfusion Mismatch V1.0 is an intelligent, automated software solution designed for rapid and accurate post-processing of Magnetic Resonance (MR) imaging data, particularly crucial in acute ischemic stroke diagnosis. [1, 11, 14, 18, 22] This AI-driven tool seamlessly integrates into clinical workflows, providing instant qualitative and quantitative parameters to enhance collaboration and optimize evaluation methodology for various pathologies. [1, 4, 5, 18]
The software offers automated diffusion-perfusion mismatch analysis, which is vital for identifying the infarct core and penumbra in stroke patients, aiding in critical treatment decisions. [11, 14, 15, 18, 22, 25] It provides quantitative analysis of hypoperfused tissue volume, ADC lesion volume, and DWI-FLAIR volumes mismatch. [1, 14, 18, 22] Built on proprietary Bayesian algorithms and advanced optimization methods, Olea Medical’s solutions are recognized for their speed, stability, and efficacy, transforming MR and CT datasets into clear, actionable insights within a unified workflow. [4, 5, 8, 17, 18]
Key functionalities include no-click access to quantitative information, CBV corrected and permeability maps computation, ADC mapping, and structured reporting with automatic export to PACS and email. [1, 4, 18] The system is vendor-neutral, compatible with a wide range of MR and CT scanners, and supports an enhanced intuitive workflow. [1, 5, 6, 19, 20] A dedicated mobile application further supports neuroradiologists by delivering real-time alerts, notifications, and patient image overviews, enabling faster and more consistent decisions in time-sensitive emergency settings. [4, 18]
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated Diffusion-Perfusion Mismatch analysis
- Quantitative analysis of stroke parameters (e.g., hypoperfused tissue volume, ADC lesion volume)
- Fast and accurate image processing
- Seamless integration into clinical workflows (PACS, email)
- Vendor-neutral compatibility with MR and CT scanners
- AI-driven detection, quantification, and structured reporting
- Dedicated mobile application for real-time alerts and image overview
- Proprietary Bayesian algorithms for improved signal processing
- DWI-FLAIR volumes mismatch assessment for infarct dating
- Automated restrictive diffusion and threshold-based hypo-perfused volume extraction
Use Cases
- Acute ischemic stroke diagnosis and treatment decision support
- Neurovascular emergency solutions for rapid triage
- Brain tumor diagnosis and assessment (as part of broader Olea solutions)
- Optimizing clinical productivity and radiology workflow
- Longitudinal analysis and response-to-treatment assessment
- Functional brain connectivity assessments (related to broader neuro imaging capabilities)
What Physicians Need to Know
Leverage Olea Medical's MR Diffusion Perfusion Mismatch tool for rapid, objective, and standardized assessment of acute ischemic stroke. Focus on utilizing the automated lesion segmentation, volume calculation, and perfusion mapping to quickly identify the ischemic penumbra and differentiate it from the necrotic core, which is critical for timely therapeutic decision-making regarding thrombolysis or thrombectomy. The tool can assist in personalizing treatment strategies, even for patients presenting beyond standard timeframes. Integrate the automated reports and mobile notifications into your workflow to enhance communication and accelerate patient management, ultimately improving patient outcomes.
Olea Medical's solutions are designed as multi-vendor post-processing tools compatible with various MRI and CT scanners. The Neurovascular Solution seamlessly integrates AI-driven detection and reporting directly into Picture Archiving and Communication Systems (PACS). Automated, customizable reports can be exported to PACS and via email. Strategic partnerships, such as with Brainomix for the e-STROKE SUITE and Pulsara for mobile neurovascular care applications, further enhance workflow integration and communication within stroke care networks.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact vendor for details — Not publicly available |
| Deployment | On-premise or thin-client deployment; contact vendor for specific cloud options and integration details. [19, 20] |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated MR Diffusion Perfusion Mismatch V1.0 received 510(k) clearance (K223502) from the U.S. FDA on January 13, 2023. It is classified under regulation 21 CFR 892.2050 (Medical image management and processing system) with product code LLZ and was determined substantially equivalent to the predicate device Olea Sphere V3.0 (K152602). [12, 16] |
| Integrations | |
| EHR | Not specified |
| Specialties | Interventional Radiology, Neurology, Radiology |
What the Web Says
MR Diffusion Perfusion Mismatch, particularly as implemented in Olea Medical's Olea Sphereu00ae software, is a tool used by physicians to assess acute ischemic stroke patients and identify salvageable brain tissue (penumbra). The software automatically calculates core, penumbra, and mismatch ratios using MR diffusion and perfusion images, aiding in timely treatment decisions. While considered a cornerstone of modern medical imaging for neurological disorders and increasingly for other body illnesses like cancer, there are noted discrepancies in volume estimations when comparing different software packages.
Overall: MixedStrengths
- Provides automated calculation of infarct core, penumbra, and mismatch ratio, which is crucial for rapid decision-making in acute ischemic stroke.
- Aids in selecting patients for treatments like mechanical thrombectomy by applying inclusion and exclusion criteria from clinical trials.
- Offers robust and efficient software solutions for the healthcare community, built upon diffusion MRI and IVIM MRI.
- Can be reviewed directly within local PACS systems, on mobile devices, or via a web-based interface, providing flexibility for physicians.
- Utilizes advanced techniques like Bayesian post-processing, which has shown to outperform other methods for reduced-contrast-dose perfusion.
- The concept of perfusion-diffusion mismatch is a qualitative marker for potential infarct expansion, helping to identify brain tissue at risk.
Limitations
- Automated MRI perfusion-diffusion mismatch estimations can differ significantly between various software packages, potentially leading to different treatment decisions for individual patients.
- Olea Sphereu00ae has been observed to estimate larger volumes for hypoperfused tissue and perfusion-diffusion mismatch compared to other software like RAPIDu00ae.
- The concept of PDM does not always optimally define the ischemic penumbra, as early DWI abnormalities can overestimate the infarct core and PWI abnormalities can overestimate the penumbra.
- MRI evaluation for acute ischemic stroke can be time-consuming and costly, with equipment limitations and patient-related challenges.
- Mismatch alone does not consistently distinguish patients with good and poor prognoses, as both can have positive or negative outcomes.
- Perfusion imaging can be more challenging for acute stroke patients compared to diffusion imaging.
Based on reviews from: The Diffusion saga - Olea Medical, Clock around the stroke | Olea Medical, Automated MRI perfusion-diffusion mismatch estimation may be significantly different in individual patients when using different software packages - PMC, MRI software for diffusion-perfusion mismatch analysis may impact on patients' selection and clinical outcome - PMC, (PDF) Automated MRI perfusion-diffusion mismatch estimation may be significantly different in individual patients when using different software packages - ResearchGate, Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update, Olea Medical touts clinical study | AuntMinnie, Olea Medical - Predictive Imaging, Comparison the Perfusion/Diffusion Mismatching Judging From CT-Based and MR-Based Study - Journal of Neurointensive Care, MRI software for diffusion-perfusion mismatch analysis may impact on patients' selection and clinical outcome - OUCI, Current concepts on magnetic resonance imaging (MRI) perfusion-diffusion assessment in acute ischaemic stroke: a review & an update for the clinicians - Indian Journal of Medical Research, Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update, A practical assessment of magnetic resonance diffusion-perfusion mismatch in acute stroke: observer variation and outcome - PubMed, Oligo/Perfusion MRI : r/braincancer - Reddit, Automated MRI perfusion-diffusion mismatch estimation may be significantly different in individual patients when using different software packages - PubMed
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate MR Diffusion Perfusion Mismatch
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for MR Diffusion Perfusion Mismatch.
Nicoletta Anzalone, MD & Maurizio Barbera, MD: "Multiparametric MRI in brain tumors" (#17)
Olea Medical
